News >

GI Cancer Treatment Continues to Evolve, But Unmet Needs Remain

Brandon Scalea
Published: Friday, Nov 30, 2018

Cathy Eng, MD

Cathy Eng, MD
A number of unmet needs have been addressed in the gastrointestinal (GI) cancer space, but there are still large patient populations who rely on traditional treatment regimens, said Cathy Eng, MD.

For example, in colorectal cancer (CRC), immunotherapy has had a significant impact in patients who have microsatellite instability-high (MSI-H) tumors. However, the vast majority of patients who are microsatellite stable (MSS) are still treated with chemotherapy, noted Eng, a professor of Gastrointestinal Medical Oncology at The University of Texas MD Anderson Cancer Center.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
The Patient and Provider Connection™: Effective Communication to Optimize the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic ConstipationOct 31, 20191.0
Publication Bottom Border
Border Publication
x